DrugPatentWatch Database Preview
ADDERALL XR 20 Drug Profile
Which patents cover Adderall Xr 20, and what generic alternatives are available?
Adderall Xr 20 is a drug marketed by Shire and is included in one NDA. There are four patents protecting this drug.
This drug has ten patent family members in eight countries.
The generic ingredient in ADDERALL XR 20 is amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate. There are fifty-four drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate profile page.
Summary for ADDERALL XR 20
| International Patents: | 10 |
| US Patents: | 4 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 6 |
| Bulk Api Vendors: | 1 |
| Clinical Trials: | 33 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | ADDERALL XR 20 at DailyMed |
Pharmacology for ADDERALL XR 20
| Drug Class | Central Nervous System Stimulant |
| Physiological Effect | Central Nervous System Stimulation |
US Patents and Regulatory Information for ADDERALL XR 20
International Patents for ADDERALL XR 20
| Country | Document Number | Estimated Expiration |
|---|---|---|
| European Patent Office | 1977736 | ➤ Try a Free Trial |
| Japan | 2002527468 | ➤ Try a Free Trial |
| European Patent Office | 1123087 | ➤ Try a Free Trial |
| Germany | 69940673 | ➤ Try a Free Trial |
| Australia | 1214500 | ➤ Try a Free Trial |
| Japan | 2008303223 | ➤ Try a Free Trial |
| Spain | 2323910 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
